CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00044018 · COMPLETED

Trial details

NCT number: NCT00044018
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2002-04-01
Primary completion: 2004-12-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.